The Japanese Experience with Metabolic Imaging in the Clinical Setting

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2007 Jun 30

PMID 17556183

Citations 5

Authors

Nagara Tamaki

Koichi Morita

Yuko Kawai

Affiliations

Soon will be listed here.

Citing Articles

Light up heart-type fatty acid binding protein (FABP3) with a novel fluorine-18 labelled selective FABP3 ligand.

Toyohara J, Komoda T, Tago T, Ito M, Yoshino H EJNMMI Res. 2024; 14(1):107.

PMID: 39542944 PMC: 11564661. DOI: 10.1186/s13550-024-01175-6.

Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers.

Cerqueira M, Case J, Maddahi J J Nucl Cardiol. 2015; 22(4):730-9.

PMID: 26129941 DOI: 10.1007/s12350-015-0199-z.

Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Yoshinaga K, Naya M, Shiga T, Suzuki E, Tamaki N Eur J Nucl Med Mol Imaging. 2013; 41(2):384-93.

PMID: 24218099 DOI: 10.1007/s00259-013-2615-4.

Myocardial perfusion scintigraphy: past, present and future.

Notghi A, Low C Br J Radiol. 2012; 84 Spec No 3:S229-36.

PMID: 22723530 PMC: 3473917. DOI: 10.1259/bjr/14625142.

Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.

Tamaki N, Yoshinaga K J Nucl Cardiol. 2010; 18(1):135-43.

PMID: 21082300 PMC: 3032201. DOI: 10.1007/s12350-010-9305-4.

References

Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N . Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med. 1992; 33(1):6-13. View

Kawamoto M, Tamaki N, Yonekura Y, Tadamura E, Fujibayashi Y, Magata Y . Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med. 1994; 8(1):47-54. DOI: 10.1007/BF03164986. View

Furutani Y, Shiigi T, Nakamura Y, Nakamura H, Harada M, Yamamoto T . Quantification of area at risk in acute myocardial infarction by tomographic imaging. J Nucl Med. 1998; 38(12):1875-82. View

Tamaki N, Tadamura E, Kudoh T, Hattori N, Yonekura Y, Nohara R . Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med. 1996; 23(3):272-9. DOI: 10.1007/BF00837625. View

Nishimura M, Murase M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R . Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries. Kidney Int. 2006; 69(3):553-9. DOI: 10.1038/sj.ki.5000100. View

Kawai Y, Tsukamoto E, Nozaki Y, Morita K, Sakurai M, Tamaki N . Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol. 2001; 38(7):1888-94. DOI: 10.1016/s0735-1097(01)01634-5. View

Schwaiger M, Schelbert H, Ellison D, Hansen H, Yeatman L, Vinten-Johansen J . Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol. 1985; 6(2):336-47. DOI: 10.1016/s0735-1097(85)80169-8. View

Taki J, Nakajima K, Matsunari I, Bunko H, Takada S, Tonami N . Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid. Eur J Nucl Med. 1995; 22(12):1385-92. DOI: 10.1007/BF01791146. View

Naruse H, Miyagi J, Arii T, Ohyanagi M, Iwasaki T, Jinnai K . The relationship between clinical stage, prognosis and myocardial damage in patients with Duchenne-type muscular dystrophy: five-year follow-up study. Ann Nucl Med. 2004; 18(3):203-8. DOI: 10.1007/BF02985001. View

10.

Ito T, Tanouchi J, Kato J, Morioka T, Nishino M, Iwai K . Recovery of impaired left ventricular function in patients with acute myocardial infarction is predicted by the discordance in defect size on 123I-BMIPP and 201Tl SPET images. Eur J Nucl Med. 1996; 23(8):917-23. DOI: 10.1007/BF01084365. View

11.

Yamabe H, Fujiwara S, Rin K, Ando M, Yokoyama M, Sakamoro T . Resting 123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain. Ann Nucl Med. 2000; 14(3):187-92. DOI: 10.1007/BF02987858. View

12.

Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H . Fatty acid metabolic imaging with 123I-BMIPP for the diagnosis of coronary artery disease: application to patients with diabetes mellitus and hyperlipidaemia. Nucl Med Commun. 1996; 17(8):675-80. DOI: 10.1097/00006231-199608000-00005. View

13.

Tanaka R, Nakamura T . Time course evaluation of myocardial perfusion after reperfusion therapy by 99mTc-tetrofosmin SPECT in patients with acute myocardial infarction. J Nucl Med. 2001; 42(9):1351-8. View

14.

Wackers F, Brown K, Heller G, Kontos M, Tatum J, Udelson J . American Society of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or chest pain center. J Nucl Cardiol. 2002; 9(2):246-50. DOI: 10.1067/mnc.2002.122630. View

15.

Kawai Y, Morita K, Nozaki Y, Ohkusa T, Sakurai M, Tamaki N . Diagnostic value of 123I-betamethyl-p-iodophenyl-pentadecanoic acid (BMIPP) single photon emission computed tomography (SPECT) in patients with chest pain. Comparison with rest-stress 99mTc-tetrofosmin SPECT and coronary angiography. Circ J. 2004; 68(6):547-52. DOI: 10.1253/circj.68.547. View

16.

Kawai Y, Tsukamoto E, Nozaki Y, Kishino K, Kohya T, Tamaki N . Use of 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction. Eur J Nucl Med. 1998; 25(10):1390-5. DOI: 10.1007/s002590050313. View

17.

Fujiwara S, Takeishi Y, Atsumi H, Takahashi K, Tomoike H . Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med. 1997; 38(2):175-80. View

18.

Araujo L, McFalls E, Lammertsma A, Jones T, Maseri A . Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET. J Nucl Cardiol. 2001; 8(3):339-46. DOI: 10.1067/mnc.2001.113615. View

19.

Inubushi M, Tadamura E, Kudoh T, Hattori N, Kubo S, Koshiji T . Simultaneous assessment of myocardial free fatty acid utilization and left ventricular function using 123I-BMIPP-gated SPECT. J Nucl Med. 1999; 40(11):1840-7. View

20.

Franken P, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A . Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med. 1994; 35(11):1758-65. View